News

Beam Therapeutics' base editing technology shows early promise in sickle cell and AATD, but commercial success is years away ...
Discover key highlights in healthcare stocks, including UnitedHealth's surge after a Buffett stake, Eli Lilly lawsuits, Trump pharma tariffs & Bayer's ...
The landscape of COVID-19 vaccinations for children is shifting in the US. How will this affect the upcoming virus season?
With strong hedge fund interest and a low price-to-earnings ratio, Pfizer Inc. (NYSE:PFE) secures a place on our list of the ...
Pfizer Inc. and Astellas Pharma Inc. have announced positive topline results from the Phase 3 EV-303 clinical trial (also ...